Immunic Yönetim

Yönetim kriter kontrolleri 3/4

Immunic CEO'su Daniel Vitt, Apr2019 tarihinde atandı, in görev süresi 5.58 yıldır. in toplam yıllık tazminatı $ 1.21M olup, şirket hissesi ve opsiyonları dahil olmak üzere 48.3% maaş ve 51.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.42% ine doğrudan sahiptir ve bu hisseler $ 448.48K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.6 yıl ve 4 yıldır.

Anahtar bilgiler

Daniel Vitt

İcra Kurulu Başkanı

US$1.2m

Toplam tazminat

CEO maaş yüzdesi48.3%
CEO görev süresi5.6yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi4.6yrs
Yönetim Kurulu ortalama görev süresi4yrs

Son yönetim güncellemeleri

Recent updates

We're Keeping An Eye On Immunic's (NASDAQ:IMUX) Cash Burn Rate

Oct 25
We're Keeping An Eye On Immunic's (NASDAQ:IMUX) Cash Burn Rate

Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation

Jan 22
Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation

Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Oct 13
Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?

Jun 27
Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?

Immunic sinks ~74% after hours as phase 1b psoriasis trial fails to separate from placebo

Oct 20

Immunic stock gains on $60M oversubscribed PIPE financing

Oct 10

Immunic GAAP EPS of -$0.72 in-line

Aug 04

Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Jul 27
Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely

Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Apr 13
Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Dec 24
Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?

Here's Why We're Watching Immunic's (NASDAQ:IMUX) Cash Burn Situation

Aug 13
Here's Why We're Watching Immunic's (NASDAQ:IMUX) Cash Burn Situation

We're Hopeful That Immunic (NASDAQ:IMUX) Will Use Its Cash Wisely

May 10
We're Hopeful That Immunic (NASDAQ:IMUX) Will Use Its Cash Wisely

Immunic EPS misses by $0.95

May 06

Immunic EPS misses by $0.07

Nov 05

Enrollment underway in Immunic's Phase 2 part of IMU-838 study in COVID-19

Nov 02

Immunic (IMUX) Investor Presentation - Slideshow

Oct 31

CEO Tazminat Analizi

Daniel Vitt'un ücretlendirmesi Immunic'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$95m

Mar 31 2024n/an/a

-US$98m

Dec 31 2023US$1mUS$585k

-US$94m

Sep 30 2023n/an/a

-US$129m

Jun 30 2023n/an/a

-US$127m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$3mUS$520k

-US$120m

Sep 30 2022n/an/a

-US$85m

Jun 30 2022n/an/a

-US$83m

Mar 31 2022n/an/a

-US$79m

Dec 31 2021US$2mUS$399k

-US$93m

Sep 30 2021n/an/a

-US$83m

Jun 30 2021n/an/a

-US$77m

Mar 31 2021n/an/a

-US$70m

Dec 31 2020US$1mUS$381k

-US$44m

Sep 30 2020n/an/a

-US$41m

Jun 30 2020n/an/a

-US$36m

Mar 31 2020n/an/a

-US$39m

Dec 31 2019US$2mUS$202k

-US$35m

Tazminat ve Piyasa: Daniel 'nin toplam tazminatı ($USD 1.21M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 653.78K ).

Tazminat ve Kazançlar: Daniel 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Daniel Vitt (56 yo)

5.6yrs

Görev süresi

US$1,211,839

Tazminat

Dr. Daniel Vitt, PhD has been the Chief Executive Officer of Immunic, Inc. since April 2019 and also served as its President until July 12, 2024. He is also managing director of Immunic Research GmbH in Ha...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Duane Nash
Executive Chairman5.8yrsUS$648.93k0.024%
$ 26.2k
Daniel Vitt
CEO & Director5.6yrsUS$1.21m0.42%
$ 448.5k
Glenn Whaley
Chief Financial Officer4.6yrsUS$702.21k0.028%
$ 30.4k
Andreas Muehler
Chief Medical Officer8.3yrsUS$845.29k0.36%
$ 382.9k
Jason Tardio
COO & Presidentless than a yearVeri yokVeri yok
Hella Kohlhof
Chief Scientific Officer7.8yrsVeri yokVeri yok
Jessica Breu
Head of Investor Relations & Communicationsno dataVeri yokVeri yok
Inderpal Singh
General Counsel3.4yrsVeri yokVeri yok
Patrick Walsh
Chief Business Officer3.1yrsVeri yokVeri yok
Werner Gladdines
Chief Development Officerless than a yearVeri yokVeri yok

4.6yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim: IMUX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.6 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Duane Nash
Executive Chairman5.8yrsUS$648.93k0.024%
$ 26.2k
Daniel Vitt
CEO & Director5.6yrsUS$1.21m0.42%
$ 448.5k
Barclay Phillips
Lead Independent Director5yrsUS$99.16k0.088%
$ 94.7k
Tamar Howson
Independent Director5.1yrsUS$75.97k0.088%
$ 94.7k
Jorg Neermann
Independent Director5.6yrsUS$82.95k0.11%
$ 119.0k
Paul Utz
Member of Scientific Medical Advisory Board4yrsVeri yokVeri yok
Bruce Sands
Member of Scientific Medical Advisory Board4yrsVeri yokVeri yok
Fred Lublin
Member of Scientific Medical Advisory Board4yrsVeri yokVeri yok
Richard Rudick
Independent Director1.6yrsUS$95.70k0%
$ 0
Simona Skerjanec
Directorless than a yearVeri yokVeri yok
Monika Tornsen
Independent Director2.3yrsUS$79.67k0.041%
$ 43.9k

4.0yrs

Ortalama Görev Süresi

58.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IMUX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4 yıldır).